Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Pharm Res. 2015 Mar 4;32(8):2753–2763. doi: 10.1007/s11095-015-1660-z

Figure 5.

Figure 5

A. Kaplan-Meier survival analysis and B. change in body weight on nu/nu mice bearing SKOV-3 ovarian tumors when injected with vehicle control, cisplatin alone, myrisplatin and C6-ceramide loaded non-targeted and EGFR-targeted theranostic nanoemulsions IV via tail vein. n=6, ± S.D.